Author response for "REAL‐LIFE EXPERIENCE WITH THE COMBINATION OF POLATUZUMAB VEDOTIN, RITUXIMAB AND BENDAMUSTINE IN AGGRESSIVE B‐CELL LYMPHOMAS"
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI